These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 833742)

  • 21. Metabolism of 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether (pyridalyl) in rats after repeated oral administration and a simple physiologically based pharmacokinetic modeling in brown and white adipose tissues.
    Nagahori H; Matsunaga H; Tomigahara Y; Isobe N; Kaneko H
    Drug Metab Dispos; 2010 May; 38(5):824-32. PubMed ID: 20164113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the possible correlations between in vitro and in vivo data using commercial triamterene formulations (author's transl)].
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1980; 30(7):1158-63. PubMed ID: 7191300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene.
    Muirhead MR; Somogyi AA; Rolan PE; Bochner F
    Clin Pharmacol Ther; 1986 Oct; 40(4):400-7. PubMed ID: 3757403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological effects of phase-I- and phase-II-metabolites of triamterene (author's transl)].
    Knauf H; Mutschler E; Völger KD; Wais U
    Arzneimittelforschung; 1978; 28(8):1417-20. PubMed ID: 582409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
    Muirhead MR; Somogyi AA
    Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral triamterene disposition.
    Sörgel F; Hasegawa J; Lin ET; Williams RL
    Clin Pharmacol Ther; 1985 Sep; 38(3):306-12. PubMed ID: 4028626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug treatment in the elderly: special aspects of diuretics (author's transl)].
    Mühlberg W; Platt D
    Aktuelle Gerontol; 1982 Jul; 12(4):134-8. PubMed ID: 6126136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Saluretic and diuretic effects of xipamide-triamterene combinations in varying dose ratios in rats].
    Armah B; Dies R; Heinz N
    Arzneimittelforschung; 1983; 33(1):131-5. PubMed ID: 6681965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Animal experimental and human pharmacologic studies with phase-II metabolites of triamterene].
    Völger KD
    Arzneimittelforschung; 1991 May; 41(5):499-506. PubMed ID: 1898420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of various vehicles and vehicle volumes on oral absorption of triamterene in rats.
    Patton TF; Gilford P
    J Pharm Sci; 1981 Oct; 70(10):1131-4. PubMed ID: 7299646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, natriuretic, antikaliuretic and antimagnesiuretic properties of an acidic triamterene derivative.
    Netzer T; Ullrich F; Majewski M; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):807-11. PubMed ID: 1418034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of tissue distribution and elimination of pyrene and 1-hydroxypyrene following intravenous administration of [14C]pyrene in rats.
    Bouchard M; Krishnan K; Viau C
    Toxicol Sci; 1998 Nov; 46(1):11-20. PubMed ID: 9928664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Handling of triamterene by the isolated perfused rat kidney.
    Kau ST
    J Pharmacol Exp Ther; 1978 Sep; 206(3):701-9. PubMed ID: 702330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies with triamterene derivatives for oral application.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(12):1819-21. PubMed ID: 4096735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW; Ballantyne B; Leung HW
    Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and metabolism of tomoxiprole, a new analgesic antiinflammatory agent, in the rat.
    Assandri A; Bernareggi A; Ripamonti A; Perazzi A; Toja E
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):161-70. PubMed ID: 4043144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of triamterene and hydroxytriamterene sulfuric acid ester on diuresis and saluresis in rats after oral and intravenous application.
    Leilich G; Knauf H; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):949-53. PubMed ID: 7191270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
    Dao MT; Villeneuve JP
    Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.